Apheresis Market Research Report, By Products (Devices and Disposables), By Procedures (Plateletpheresis, Leukapheresis, Erythrocytapheresis, Plasmapheresis), By Methods (Centrifugation And Filtration), By Application (Oncological Diseases, Renal Diseases, Cardiovascular Diseases, Haematological Diseases, Neurological Diseases, Immunological Diseases) And By End Users (Blood Banks, Hospitals) – Global Forecast to 2027

Apheresis Market scenario:

Apheresis is the medical technology which is used for the purification of the blood or separation of different component of blood. It involves removing of the blood from the donor or patients and collecting it into an apparatus which separates the desired component from the blood, while the rest of the blood is send back to the donor or patients. This separation of the component was done by two process namely centrifugation and filtration. Global apheresis market is driven by development in the new apheresis techniques and increasing prevalence of different chronic diseases, blood related diseases and many more. Increasing demand for the different component of the bloods, rising complex surgical procedures and increasing number of accidents across the globe has also contributed in the growth of the market. According to National Health Service (NHS) Blood and Transplant, the demand for platelets. While lack of skilled professional and Blood and blood product can be infected very easily, this risk of infection also contribute in hindering the market growth.

Apheresis Market is increasing at a rapid pace which is expected to grow at a CAGR of 10.2% during forecasted period 2017-2023.

Apheresis Market Segmentation:

Global apheresis market is segmented on the basis of product into devices and disposables. Devices are further segmented into plasma separators, platelets separators and other. On the basis of procedures, they are plateletpheresis, leukapheresis, erythrocytapheresis, plasmapheresis and other. On the basis of methods they are centrifugation and filtration. Centrifugation is further segmented into continuous flow centrifugation, intermittent flow centrifugation and other. On the basis of application, the market is segmented into oncological diseases, renal diseases, cardiovascular diseases, haematological diseases, immunological diseases, neurological diseases and other and on the basis of end user they are blood banks, hospitals and other.

Study Objectives Global Apheresis Market:

Detail analysis of global apheresis market with region specific growth and competitive analysis on the basis of major players present in the market

Detail analysis of global apheresis market and different drivers and restraints affecting the growth of the market

Detailed analysis of the historical and forecasted market analysis of the market on the basis of factors like- price analysis, supply chain analysis, porters five force analysis etc.

To track and analyze competitive developments such as joint ventures, strategic alliances, mergers and acquisitions, new product developments, and research and developments in the global apheresis

Detail analysis on the possible segments and sub segments of the market. And regional analysis of the market- Americas, Europe, Asia Pacific and Middle East and Africa.

Insights on the major countries/regions in which these major industries is flourishing and to also identify the untapped regions which could be the potential markets in future

Intended Audience

• Apheresis manufacturers


• Apheresis suppliers


• Research and Development (R&D) Companies


• Government Research Laboratories


• Independent Research Laboratories


• Government and Independent Regulatory Authorities


• Market Research and Consulting Service Providers


• Medical Research Laboratories


• Academic Medical Institutes and Universities

Regional analysis:

On regional basis, Americas hold the largest share in the global apheresis market. Continuous advance in technology, increasing opportunity for apheresis products and presence of a huge number of people suffering from different chronic diseases has spurred the growth of this market in Americas. Europe is the second leading market which is followed by Asia Pacific. However Asia Pacific is the fastest growing region for the market. Increasing demand for different blood components for the patients, rapid development in healthcare and increasing healthcare expenditure are contributing in the growth of Asia Pacific apheresis market.

Key Players For Global Apheresis Market:

Asahi Kasei Medical Co. Ltd. (Japan), Fresenius Medical Care (Germany), Terumo BCT, Inc. (US), Haemonetics Corporation (US), Kawasumi Laboratories Inc. (Japan), HemaCare Corporation (US), Kaneka Corporation (Japan), and Nikkiso Co., Ltd. (Japan), Cerus Corporation (US), B. Braun Melsungen AG (Germany), Nikkiso Ltd. (Japan), Therakos, Inc. (US).

Market Assessment

The report for global apheresis market of Market Research Future comprises of extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain the deeper insight of the market and industry performance. The report gives the clear picture of current market scenario which includes historical and projected market size in terms of value and volume, technological advancement, macro economical and governing factors in the market. The report provides details information and strategies of the top key players in the industry. The report also gives a broad study of the different markets segments and regions.

Report Scope:

Report Attribute/Metric	Details
Market Size	Significant Value
CAGR	10.2% (2017-2023)
Base Year	2019
Forecast Period	2020-2027
Historical Data	2018
Forecast Units	Value (USD Million)
Report Coverage	Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
Segments Covered	Products, Procedures, Methods, Application and End Users
Geographies Covered	North America, Europe, Asia-Pacific, and Rest of the World (RoW)
Key Vendors	Asahi Kasei Medical Co. Ltd. (Japan), Fresenius Medical Care (Germany), Terumo BCT, Inc. (US), Haemonetics Corporation (US), Kawasumi Laboratories Inc. (Japan), HemaCare Corporation (US), Kaneka Corporation (Japan), and Nikkiso Co., Ltd. (Japan), Cerus Corporation (US), B. Braun Melsungen AG (Germany), Nikkiso Ltd. (Japan), Therakos, Inc. (US).
Key Market Opportunities	Increasing demand for the different component of the bloods
Key Market Drivers	Development in the new apheresis techniques and increasing prevalence of different chronic diseases, blood related diseases

Frequently Asked Questions (FAQ) :

---